title: Bleeding Academic Research Consortium consensus report: the Food and Drug Administration perspective.
authors.forename: Karen A
authors.initials: KA
authors.lastname: Hicks
authors.forename: Norman L
authors.initials: NL
authors.lastname: Stockbridge
authors.forename: Shari L
authors.initials: SL
authors.lastname: Targum
authors.forename: Robert J
authors.initials: RJ
authors.lastname: Temple
mesh_terms: D000925:Anticoagulants / Q000009:adverse effects*; D032921:Consensus; D004348:Drug Labeling / Q000592:standards*; D006470:Hemorrhage / Q000139:chemically induced / Q000453:epidemiology / Q000517:prevention & control*; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects*; D012307:Risk Factors; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors